ArticleBiomedical optics express2024
Employing texture loss to denoise OCT images using generative adversarial networks.
Article in Biomedical optics express, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 10 citations in OpenAlex.
- Deep learning-enabled speckle reduction for cleared-sample coherent scattering tomography.bioRxiv : the preprint server for biology · 2026Article
- Enhancement of Optical Coherence Tomography Images Using Adversarial Neural Networks: Impacts on Ophthalmic Practice.Cureus · 2025Article
- A Future Picture: A Review of Current Generative Adversarial Neural Networks in Vitreoretinal Pathologies and Their Future Potentials.Biomedicines · 2025Review
- Article
- Artificial intelligence-assisted retinal imaging enables dense pixel sampling from sparse measurements.NPJ artificial intelligence · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
OCT is a widely used clinical ophthalmic imaging technique, but the presence of speckle noise can obscure important pathological features and hinder accurate segmentation. This paper presents a novel method for denoising optical coherence tomography (OCT) images using a combination of texture loss and generative adversarial networks (GANs). Previous approaches have integrated deep learning techniques, starting with denoising Convolutional Neural Networks (CNNs) that employed pixel-wise losses. While effective in reducing noise, these methods often introduced a blurring effect in the denoised OCT images. To address this, perceptual losses were introduced, improving denoising performance and overall image quality. Building on these advancements, our research focuses on designing an image reconstruction GAN that generates OCT images with textural similarity to the gold standard, the averaged OCT image. We utilize the PatchGAN discriminator approach as a texture loss to enhance the quality of the reconstructed OCT images. We also compare the performance of UNet and ResNet as generators in the conditional GAN (cGAN) setting, as well as compare PatchGAN with the Wasserstein GAN. Using real clinical foveal-centered OCT retinal scans of children with normal vision, our experiments demonstrate that the combination of PatchGAN and UNet achieves superior performance (PSNR = 32.50) compared to recently proposed methods such as SiameseGAN (PSNR = 31.02). Qualitative experiments involving six masked clinical ophthalmologists also favor the reconstructed OCT images with PatchGAN texture loss. In summary, this paper introduces a novel method for denoising OCT images by incorporating texture loss within a GAN framework. The proposed approach outperforms existing methods and is well-received by clinical experts, offering promising advancements in OCT image reconstruction and facilitating accurate clinical interpretation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.